Evidence map›Paper›PMID 22869261›Full record

ArticleInfection control and hospital epidemiology2012

Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey.

Kerri A Thom, Lisa L Maragakis, Katie Richards, J Kristie Johnson, Brenda Roup, Patricia Lawson, Anthony D Harris, Elizabeth P Fuss, Margaret A Pass, David Blythe and 3 more

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Prevalence ofJournal of clinical microbiology · 2026
    Article
  2. Article
  3. Article
  4. The global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2025
    Review
  5. Article
  6. Trends in Antimicrobial Resistance ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Prevalence and risk factors for carriage of carbapenem-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  8. Prevalence of carbapenemase-producing organisms among hospitalized solid organ transplant recipients, five US hospitals, 2019-2020.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  9. Pathogenesis of Gram-Negative Bacteremia.Clinical microbiology reviews · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kerri A ThomUniversity of Maryland School of Medicine, Baltimore, Maryland, USA. kthom@epi.umaryland.edu
Lisa L Maragakis
Katie Richards
J Kristie Johnson
Brenda Roup
Patricia Lawson
Anthony D Harris
Elizabeth P Fuss
Margaret A Pass
David Blythe
Eli N Perencevich
Lucy Wilson
Maryland MDRO Prevention Collaborative

Funding

Clinical Research Career Development (RMI)K12RR023250 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2005 to 2009
$13.3M
Epidemiology of imipenem-resistant P.aeruginosaR01AI060859 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRIS, ANTHONY D · 2005 to 2013
$1.9M
K24 Clinical Research in Antimicrobial Resistance and Hospital EpidemiologyK24AI079040 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRIS, ANTHONY D · 2009 to 2018
$1.8M
Epidemiology of Acinetobacter baumannii: An Emerging Nosocomial PathogenK23AI082450 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI THOM, KERRI · 2010 to 2014
$674k
NCRR NIH HHS 1K12RR023250-04NCRR NIH HHS K12 RR023250NIAID NIH HHS K1K23AI082450-01A1NIAID NIH HHS K23 AI082450NIAID NIH HHS K24 AI079040NIAID NIH HHS K24AI079040NIAID NIH HHS R01 AI060859NIAID NIH HHS R01AI60859-01A1PHS HHS 2R01A1060859
6 · The paper itself

Abstract

objectiveTo determine the prevalence of Acinetobacter baumannii, an important healthcare-associated pathogen, among mechanically ventilated patients in Maryland.

designThe Maryland MDRO Prevention Collaborative performed a statewide cross-sectional active surveillance survey of mechanically ventilated patients residing in acute care and long-term care (LTC) facilities. Surveillance cultures (sputum and perianal) were obtained from all mechanically ventilated inpatients at participating facilities during a 2-week period.

settingAll healthcare facilities in Maryland that provide care for mechanically ventilated patients were invited to participate. PATIENTS: Mechanically ventilated patients, known to be at high risk for colonization and infection with A. baumannii, were included.

resultsSeventy percent (40/57) of all eligible healthcare facilities participated in the survey, representing both acute care ([Formula: see text]) and LTC ([Formula: see text]) facilities in all geographic regions of Maryland. Surveillance cultures were obtained from 92% (358/390) of eligible patients. A. baumannii was identified in 34% of all mechanically ventilated patients in Maryland; multidrug-resistant A. baumannii was found in 27% of all patients. A. baumannii was detected in at least 1 patient in 49% of participating facilities; 100% of LTC facilities had at least 1 patient with A. baumannii, compared with 31% of acute care facilities. A. baumannii was identified from all facilities in which 10 or more patients were sampled.

conclusionsA. baumannii is common among mechanically ventilated patients in both acute care and LTC facilities throughout Maryland, with a high proportion of isolates demonstrating multidrug resistance.

Indexed as

Cost of IllnessRespiration, ArtificialAcinetobacter baumanniiAcinetobacter InfectionsCross InfectionCross-Sectional StudiesDrug Resistance, BacterialHealth Care SurveysHospitalsHumansMarylandPrevalencePublic Health SurveillanceResidential Facilities

Identifiers

PMID22869261
PMCPMC3720130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.